These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
171 related items for PubMed ID: 38399956
21. Human parvovirus B19 infection in multiple sclerosis. Nakashima I, Fujihara K, Itoyama Y. Eur Neurol; 1999 Jul; 42(1):36-40. PubMed ID: 10394046 [Abstract] [Full Text] [Related]
22. Prevalence and Phylogenetic Analysis of Parvovirus (B19V) among Blood Donors with Different Nationalities Residing in Qatar. Abdelrahman D, Al-Sadeq DW, Smatti MK, Taleb SA, AbuOdeh RO, Al-Absi ES, Al-Thani AA, Coyle PV, Al-Dewik N, Qahtani AAA, Yassine HM, Nasrallah GK. Viruses; 2021 Mar 24; 13(4):. PubMed ID: 33805034 [Abstract] [Full Text] [Related]
23. Seroprevalence and geographical distribution of parvovirus B19 antibodies in pregnant women: A-meta analysis. Moosazadeh M, Alimohammadi M, Mousavi T. J Immunoassay Immunochem; 2023 Mar 04; 44(2):103-116. PubMed ID: 36661768 [Abstract] [Full Text] [Related]
24. A high prevalence of parvovirus B19 DNA in patients with psoriasis. Yazici AC, Aslan G, Baz K, Ikizoglu G, Api H, Serin MS, Tezcan S, Emekdas G, Tasdelen B. Arch Dermatol Res; 2006 Oct 04; 298(5):231-5. PubMed ID: 16862431 [Abstract] [Full Text] [Related]
25. [Observations on human parvovirus B19 infection diagnosed in 2011]. Mihály I, Trethon A, Arányi Z, Lukács A, Kolozsi T, Prinz G, Marosi A, Lovas N, Dobner IS, Prinz G, Szalai Z, Pék T. Orv Hetil; 2012 Dec 09; 153(49):1948-57. PubMed ID: 23204301 [Abstract] [Full Text] [Related]
26. [Seroprevalence of anti-human parvovirus B19 antibodies in a sample of blood donors in Galicia]. Mata Rebón M, Bartolomé Husson C, Bernárdez Hermida I. Enferm Infecc Microbiol Clin; 1998 Jan 09; 16(1):25-7. PubMed ID: 9542305 [Abstract] [Full Text] [Related]
27. The prevalence of antibody to human parvovirus B19 in pregnant women in Kuwait. Maksheed M, Pacsa AS, Essa SS, Ahmed MA, Monem RA, Surkouh M. Acta Trop; 1999 Oct 15; 73(3):225-9. PubMed ID: 10546839 [Abstract] [Full Text] [Related]
28. Seroprevalence of parvovirus B19 in fibromyalgia syndrome. Buyukkose M, Kozanoglu E, Basaran S, Bayramoglu O, Yarkin F. Clin Rheumatol; 2009 Mar 15; 28(3):305-9. PubMed ID: 19057847 [Abstract] [Full Text] [Related]
29. Serologic study of human parvovirus B19 infection in pregnancy in Japan. Yaegashi N, Niinuma T, Chisaka H, Uehara S, Okamura K, Shinkawa O, Tsunoda A, Moffatt S, Sugamura K, Yajima A. J Infect; 1999 Jan 15; 38(1):30-5. PubMed ID: 10090504 [Abstract] [Full Text] [Related]
30. Acute parvovirus B19 infection: analysis of 46 patients. Tomás-Velázquez A, Escribano Á, Rodríguez-Garijo N, Estenaga Pérez de Álbeniz Á, Reina G, España A. Med Clin (Barc); 2020 Jul 10; 155(1):26-29. PubMed ID: 32143947 [Abstract] [Full Text] [Related]
31. A study by means of a new assay of the relationship between an outbreak of erythema infectiosum and non-immune hydrops fetalis caused by human parvovirus B19. Yaegashi N, Okamura K, Tsunoda A, Nakamura M, Sugamura K, Yajima A. J Infect; 1995 Nov 10; 31(3):195-200. PubMed ID: 8586838 [Abstract] [Full Text] [Related]
32. Detection of parvovirus B19 in synovial fluids of patients with osteoarthritis. Aslan B, Serin MS, Aslan G, Kalaci A, Yanat AN, Tezcan S, Emekdas G. Diagn Microbiol Infect Dis; 2008 Apr 10; 60(4):381-5. PubMed ID: 18096351 [Abstract] [Full Text] [Related]
33. Human parvovirus B19: relevance in internal medicine. van Elsacker-Niele AM, Kroes AC. Neth J Med; 1999 Jun 10; 54(6):221-30. PubMed ID: 10399450 [Abstract] [Full Text] [Related]
34. [Parvovirus B19 outbreak in a rural community in Alicante]. Martínez-Campillo F, López J, Verdú M, Andreu M, Rigo MV. Enferm Infecc Microbiol Clin; 2002 Oct 10; 20(8):376-9. PubMed ID: 12372232 [Abstract] [Full Text] [Related]
35. [Comparative study of indirect immunofluorescence (IIF) and ELISA techniques in the detection of parvovirus B19]. González M, Hassanhi M, Rivera S, Bracho MP. Invest Clin; 2000 Mar 10; 41(1):19-27. PubMed ID: 10758696 [Abstract] [Full Text] [Related]
36. [Parvovirus B19 infection: the general aspects and gestational problems]. Di Stefano L, Carta G, Barnabei R, Tomei E, Toro G, Moscarini M. Minerva Ginecol; 1995 Apr 10; 47(4):121-5. PubMed ID: 7644092 [Abstract] [Full Text] [Related]
37. Prevalence of parvovirus B19 antibodies in pregnant women in northern Benin. De Paschale M, Ceriani C, Cerulli T, Cagnin D, Cavallari S, Zaongo D, Diombo K, Priuli G, Viganò P, Finazzi S, Clerici P. Trop Med Int Health; 2023 Mar 10; 28(3):226-231. PubMed ID: 36647788 [Abstract] [Full Text] [Related]
38. The seroprevalence of parvovirus B19 infection among to-be-married girls, pregnant women, and their neonates in Shiraz, Iran. Ziyaeyan M, Rasouli M, Alborzi A. Jpn J Infect Dis; 2005 Apr 10; 58(2):95-7. PubMed ID: 15858287 [Abstract] [Full Text] [Related]
39. Seroprevalence, molecular epidemiology and quantitation of parvovirus B19 DNA levels in Iranian blood donors. Zadsar M, Aghakhani A, Banifazl M, Kazemimanesh M, Tabatabaei Yazdi SM, Mamishi S, Bavand A, Sadat Larijani M, Ramezani A. J Med Virol; 2018 Aug 10; 90(8):1318-1322. PubMed ID: 29663448 [Abstract] [Full Text] [Related]
40. Parvovirus B19 infection in Hong Kong. Lim WL, Wong KF, Lau CS. J Infect; 1997 Nov 10; 35(3):247-9. PubMed ID: 9459396 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]